Scientists have found a way to supercharge lung cancer treatment by transplanting healthy mitochondria into tumors, which both boosts immune response and makes chemotherapy far more effective. By ...
Although all authors completed the disclosure declaration, the following author(s) indicated a financial or other interest that is relevant to the subject matter under consideration in this article.
Response to Biologics in Patients With Early-Onset Treatment-Naïve Metastatic Colorectal Cancer—An Aide et Recherche en Cancérologie Digestive Database Analysis Overall, 240 patients were randomly ...
The odds of cisplatin-induced acute kidney injury decreased with prophylactic administration of intravenous magnesium. Infusing prophylactic magnesium before initiating intravenous cisplatin for ...
BERLIN — Perioperative treatment with the antibody-drug conjugate enfortumab vedotin (EV) and the immune checkpoint inhibitor pembrolizumab in muscle-invasive bladder cancer (MIBC) patients who are ...
EU CHMP recommends approval of Merck’s Keytruda plus Padcev as perioperative treatment for adults with cisplatin-ineligible resectable muscle-invasive bladder cancer: Rahway, Ne ...
Cisplatin-based NAC and AMVAC improved two-year MFS in MIBC patients, with a 72.9% overall MFS rate. 17% of all patients and 48% in the AS group avoided cystectomy without metastatic disease. Severe ...
Zacks Investment Research on MSN
MRK stock gains after CHMP backs Keytruda combo for bladder cancer
Shares of Merck MRK rose nearly 6% on Friday after the company announced that the EMA’s Committee for Medicinal Products for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results